Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Vleminckx
C. Vleminckx
European Medicines Agency
European union
Medicine
Immunology
Marketing authorization
Humanities
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer.
2021
Julio Delgado
C. Vleminckx
Sinan B. Sarac
A. Sosa
Jonas Bergh
R. Giuliani
Harald Enzmann
Francesco Pignatti
Show All
Source
Cite
Save
Citations (2)
Guidelines EMA pour le développement de médicaments biosimilaires
2011
Oncologie
C. Vleminckx
F. Ehmann
Show All
Source
Cite
Save
Citations (0)
1